Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Overzicht 
James Irvin Healy is Chairman of Cincor Pharma, Inc. and General Partner at Sofinnova Investments, Inc., Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC (which are all subsidiaries of Sofinnova Investments, Inc.).

He is also Managing General Partner at Sofinnova Venture Partners VII LP, Managing Partner at Sofinnova Management VI LLC and Managing Partner at Sofinnova Management VII LLC and on the board of 10 other companies.

Dr. Healy previously held the position of Independent Director at Humanigen, Inc., Manager for ISTA Pharmaceuticals, Inc., Associate of Sanderling Ventures, Chairman for Hyperion Therapeutics, Inc., Principal at Bayer Pharmaceuticals Corp., Principal at Lawrence Berkeley National Laboratory and Director at PregLem SA.

He received an undergraduate degree from the University of California, Berkeley and a doctorate from Stanford University School of Medicine.


Posities en verantwoordelijkheden van James Irvin Healy 
NaamTitel Van
Natera, Inc.
(Medische apparatuur, benodigdheden & distributie)
Independent Director 2014
Ascendis Pharma A/S
(Biotechnologie & Medisch Onderzoek)
Independent Director 2014
Karuna Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2019
Y-mAbs Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2017
Coherus BioSciences, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2014
Bolt Biotherapeutics, Inc.
(Farmaceutische producten)
Independent Director 2021
NuCana plc
(Biotechnologie & Medisch Onderzoek)
Independent Non-Executive Director 2014
Sorbent Therapeutics, Inc. Director -
Iterum Therapeutics International Ltd. Director -
Iterum Therapeutics US Holding Ltd. Director -
Cincor Pharma, Inc. Chairman -
Sofinnova Venture Partners VII LP Managing General Partner -
Sofinnova Management VI LLC Managing Partner -
Sofinnova Management VII LLC Managing Partner 2012
Sofinnova Investments, Inc. General Partner 2000


Belangnemingen van James Irvin Healy 
NaamAandelen%Totale waarde
Coherus BioSciences, Inc. (CHRS)
(Biotechnologie & Medisch Onderzoek)
504 6410,66%8 064 163 USD
Natera, Inc. (NTRA)
(Medische apparatuur, benodigdheden & distributie)
32 4720,035%3 845 659 USD
Y-mAbs Therapeutics, Inc. (YMAB)
(Biotechnologie & Medisch Onderzoek)
62 6660,14%1 928 859 USD
NuCana Plc45 7500,14%121 695 USD
Iterum Therapeutics plc (ITRM)
(Biotechnologie & Medisch Onderzoek)
6 1540,0034%4 123 USD
Karuna Therapeutics, Inc. (KRTX)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD
Ascendis Pharma A/S00,0000%0 USD
ObsEva SA (OBSV)
(Biotechnologie & Medisch Onderzoek)
00,0000%0 USD


James Irvin HealyPersoonlijk netwerk 
Meest gelezen nieuws 
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
James Irvin Healy Verbindingen